249 related articles for article (PubMed ID: 22330721)
1. Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells.
Wang L; Liu Z; Balivada S; Shrestha T; Bossmann S; Pyle M; Pappan L; Shi J; Troyer D
Stem Cell Res Ther; 2012 Feb; 3(1):5. PubMed ID: 22330721
[TBL] [Abstract][Full Text] [Related]
2. Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo.
He S; Iwashita T; Buchstaller J; Molofsky AV; Thomas D; Morrison SJ
Dev Biol; 2009 Apr; 328(2):257-72. PubMed ID: 19389366
[TBL] [Abstract][Full Text] [Related]
3. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.
Li Y; Wang L; Pappan L; Galliher-Beckley A; Shi J
Mol Cancer; 2012 Nov; 11():87. PubMed ID: 23174018
[TBL] [Abstract][Full Text] [Related]
4. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
6. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
[TBL] [Abstract][Full Text] [Related]
7. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.
Wang SM; Lin HY; Chen YL; Hsu TI; Chuang JY; Kao TJ; Ko CY
J Neuroinflammation; 2019 Jul; 16(1):146. PubMed ID: 31300060
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
10. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
[TBL] [Abstract][Full Text] [Related]
12. UPF1/circRPPH1/ATF3 feedback loop promotes the malignant phenotype and stemness of GSCs.
Xu J; Zhang G; Hu J; Li H; Zhao J; Zong S; Guo Z; Jiang Y; Jing Z
Cell Death Dis; 2022 Jul; 13(7):645. PubMed ID: 35871061
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling.
Liu S; Zhang C; Wang B; Zhang H; Qin G; Li C; Cao L; Gao Q; Ping Y; Zhang K; Lian J; Zhao Q; Wang D; Zhang Z; Zhao X; Yang L; Huang L; Yang B; Zhang Y
Cancer Immunol Immunother; 2021 Sep; 70(9):2601-2616. PubMed ID: 33576874
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on the stem cell phenotypes of C6 cells under different culture conditions.
Zhang SJ; Ye F; Xie RF; Hu F; Wang BF; Wan F; Guo DS; Lei T
Chin Med J (Engl); 2011 Oct; 124(19):3118-26. PubMed ID: 22040566
[TBL] [Abstract][Full Text] [Related]
15. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 is required to maintain the self-renewal of glioma stem cells.
Zhu J; Wang H; Sun Q; Ji X; Zhu L; Cong Z; Zhou Y; Liu H; Zhou M
BMC Cancer; 2013 Aug; 13():380. PubMed ID: 23937621
[TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells.
Chao Q; Li X; Huang Y
J Cancer Res Ther; 2023 Dec; 19(6):1636-1645. PubMed ID: 38156932
[TBL] [Abstract][Full Text] [Related]
18. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
20. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
